Bellerophon Therapeutics, Inc.·4

May 22, 11:14 AM ET

Peacock Jonathan M 4

4 · Bellerophon Therapeutics, Inc. · Filed May 22, 2019

Insider Transaction Report

Form 4
Period: 2019-05-21
Peacock Jonathan M
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2019-05-21$0.61/sh+20,000$12,1981,875,920 total

Documents

1 file
  • 4
    wf-form4_155853806257021.xmlPrimary

    FORM 4